Kiss Goodbye to MS is celebrating its biggest year yet! A record-breaking $6.75 million for life-changing MS research has been raised in 2020.
Amber was 33 when she found out she had MS. She gives to MS research in hopes of helping researchers find a cure in her lifetime.
The Board of MS Australia has announced the appointment of Rohan Greenland as the new CEO to guide the newly amalgamated organisation.
The National Health and Medical Research Council has announced $1.4 million in funding for an MS patient-centred digital health care tool – InforMS.
Mayzent (siponimod) the first MS medication approved for secondary progessive MS in Australia, has been listed on the Pharmaceutical Benefits Scheme (PBS).
MS Research Australia has announced the funding of six new incubator grants, which are small grants designed to explore exciting and fresh ideas.
MS Research Australia has been a recipient of funding raised through the Sohn Hearts & Minds Investment Leaders Conference for the past four years.
Deeper insights into the spine’s electrical connections uncover changes in the nervous system in progressive MS and highlight the power of tissue banks.
Introduction If we thought last year’s Federal Budget was unusual, coming as it did a month early at
